Last update 01 Nov 2024
Jilin University Institute of Regenerative Medicine
Education|
China
Last update 01 Nov 2024
Overview
Tags
Cardiovascular Diseases
Nervous System Diseases
Herbal medicine
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评价伪人参皂苷GQ 注射液用于治疗稳定性心绞痛患者的有效性和安全性Ⅱa期探索性临床试验
[Translation] Phase IIa exploratory clinical trial to evaluate the efficacy and safety of pseudoginsenoside GQ injection in the treatment of patients with stable angina pectoris
伪人参皂苷GQ注射液多次给药、安慰剂对照、随机双盲，耐受性和药代动力学的Ⅰ期临床研究
[Translation] Phase I clinical study on the tolerance and pharmacokinetics of pseudoginsenoside GQ injection in a multiple-dose, placebo-controlled, randomized, double-blind manner
评价治疗稳定性心绞痛（气阴两虚证）有效性和安全性随机、双盲双模拟、阳性药对照、多中心临床试验
[Translation] A randomized, double-blind, double-dummy, active drug-controlled, multicenter clinical trial to evaluate the efficacy and safety of the treatment of stable angina pectoris (Qi and Yin deficiency syndrome)
100 Clinical Results associated with Jilin University Institute of Regenerative Medicine
Login to view more data
Login to view more data
100 Deals associated with Jilin University Institute of Regenerative Medicine
Login to view more data
100 Translational Medicine associated with Jilin University Institute of Regenerative Medicine
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 08 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
Phase 3 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free